Earnings

Sarepta Therapeutics Q3 Adj. EPS $0.13 Beats $0.06 Estimate, Sales $381.400M Beat $352.961M Estimate

Nov 5, 2026 · 04:24 PM ET· updated 1h ago

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.06 by 116.67 percent. This is a 200 percent increase over losses of $(0.13) per share

Why It Matters

Sarepta made more money than people expected this quarter. When a company beats its targets, it might mean the business is running well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SRPT17.10

-1.89 (-9.95%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.